New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8. (2018)

First Author: Fey P
Attributed to:  Proteolysis and life cycle progression in Leishmania funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2018.07.012

PubMed Identifier: 30029081

Publication URI: http://europepmc.org/abstract/MED/30029081

Type: Journal Article/Review

Volume: 156

Parent Publication: European journal of medicinal chemistry

ISSN: 0223-5234